Nutriband (NASDAQ:NTRBW) Trading Down 0.9% – Here’s Why

Nutriband Inc. (NASDAQ:NTRBW)’s share price was down 0.9% during mid-day trading on Tuesday . The company traded as low as $1.12 and last traded at $1.12. 100 shares changed hands during mid-day trading, a decline of 96% from the average daily volume of 2,391 shares. The stock had previously closed at $1.13.

Nutriband Stock Up 2.7%

The stock’s fifty day moving average price is $1.41 and its 200-day moving average price is $1.63.

Institutional Investors Weigh In On Nutriband

A hedge fund recently bought a new stake in Nutriband stock. Clear Street Group Inc. purchased a new stake in Nutriband Inc. (NASDAQ:NTRBW) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 61,590 shares of the company’s stock, valued at approximately $105,000.

Nutriband Company Profile

Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility.